Menu
  • Join
  • Login
  • Contact
 

Search abstracts


RATIONAL DESIGN OF LIVER X RECEPTOR (LXR) MODULATORS USING THE AGONIST GW3965 SCAFFOLD AS A LEAD

  • At: 2019 FIP Congress in AbuDhabi (United Arab Emirates)
  • Type: Poster
  • By: SHOEMAKE, Claire (University of Malta, Pharmacy, Malta)
  • Co-author(s): Nicole Bonello: Pharmacy, University of Malta, Msida, Malta
    Claire Shoemake: Pharmacy, University of Malta, Msida, Malta
  • Abstract:

    Background

    Pancreatic cancer, probably due to characteristic late diagnosis, is associated with high mortality. The Liver-X_Receptor (LXR) is a druggable target for the development of agonists that could mitigate pancreatic cancer development. Literature indicates that experimental molecules GW3965 and 4-(3-Aryloxyaryl) quinoline sulfone have LXR..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 13 May 2019

FIP Congresses